Baxter Healthcare Corporation's BioPharma Solutions Business Articles

BAXTER RECEIVES FAVORABLE JUDGEMENT

20 June 1994

BAXTER CORP AGREEMENT

13 June 1994

BAXTER LOOKS TO LATIN AMERICA

13 June 1994

SAFER GAMMAGARD APPROVED IN USA

23 May 1994

COURT DENIES HIV CLASS ACTION SUIT

2 May 1994

CURRENCIES STILL A FACTOR IN US 1st QTR

2 May 1994

UNITED BIOMEDICAL ORAL AIDS VACCINE

2 May 1994

THE ULTIMATE FORM OF MOLECULAR MEDICINE?

2 May 1994

BAXTER'S BJC DEAL

18 April 1994

US BREAST IMPLANT SETTLEMENT

11 April 1994

BAXTER SIGNS AGREEMENTS

4 April 1994

CANLAB PURCHASE

14 March 1994

BAXTER WITHDRAWS GAMMAGARD

14 March 1994

CORPORATE NEWS IN BRIEF

28 February 1994

HEART-ASSIST SYSTEM APPROVED IN EUROPE

28 February 1994

BREAST IMPLANT COs AGREE DEAL

21 February 1994

BAXTER HEALTHCARE DEVICE IN FDA TRIAL

14 February 1994

BIOGEN APPOINTMENT

31 January 1994

STRONG DOLLAR WEAKENS US 1993 RESULTS

31 January 1994

WORLD HEMATOLOGY MARKET FORECASTS

24 January 1994

BAXTER AGREEMENT FOR BLOOD PRODUCTS

10 January 1994

TOBIN RESIGNS FROM BAXTER

10 January 1994

BAXTER SETTLES US CONTRACTS

10 January 1994

EXPANDING PHARMA MARKET IN TURKEY

10 January 1994

BAD NEW FOR MEDIMMUNE AS RESPIGAM STUMBLES

13 December 1993

CANTAB FULLY FINANCED FOR AT LEAST TWO YEARS

13 December 1993

CANTAB AIMS FOR A LICENSE TO EXPAND

6 December 1993

BAXTER APPOINTMENT

29 November 1993

MAJOR SHAKE-UP AT BAXTER INT'L

22 November 1993

BAXTER AND SOMATIX IN GENE THERAPY DEAL

15 November 1993

US 3rd QTR AFFECTED BY STRONG DOLLAR

1 November 1993

AFFYMAX EXPANDS DRUG SCREENING CAPACITY

1 November 1993

DNX APPOINTMENT

25 October 1993

BAXTER INT'L BARRED IN NEW YORK STATE

25 October 1993

INVESTIGATIONS INTO CAREMARK ONGOING

11 October 1993

BAXTER ON STORM-TOSSED WATERS

4 October 1993

BAXTER TO PAY COMPENSATION

27 September 1993

BAXTER'S SHARES FALL 15% ON WARNING

20 September 1993

NEW YORK STOCK COMMENT

20 September 1993

NET PROFIT DOWN 11%AT RHONE-POULENC

13 September 1993

RED CROSS AS WHITE KNIGHT (OR CZECH MATE?)

13 September 1993

IMPLICATIONS OF EC PLASMA POLICY

6 September 1993

BAXTER TO APPEAL SUSPENSION

23 August 1993

BAXTER BLOOD SUBSTITUTE TESTS

2 August 1993

ADVANCES BY US DRUG COMPANIES IN 2nd QTR

26 July 1993

TAIWAN FIRM SEEKS TO CAPITALIZE ON IV DEAL WITH BAXTER

26 July 1993

NEW YORK STOCK COMMENT

19 July 1993

BAXTER/CANTAB DEAL

19 July 1993

BAXTER INT'L INVESTS IN ASIA-PACIFIC

12 July 1993

OPPORTUNITIES IN UK BIOSCIENCE SECTOR

21 June 1993

R-PR: $77 MILLION CHARGE IN 2nd QUARTER

14 June 1993

BAXTER IN CHINESE JOINT VENTURE

14 June 1993

CPMP BACKS RECOMBINATE

7 June 1993

BAXTER APPOINTMENT

31 May 1993

BAXTER INT'L HIT BY PROTEST MOVE

31 May 1993

EC SUPPORT FOR BAXTER; ENDS ROW WITH R-PR'S ARMOUR

24 May 1993

ADVANCES AND SLOW DOWNS IN US 1st QTRS

3 May 1993

US 1st QTRs IN LINE WITH EARLIER WARNINGS

26 April 1993

GENETICS INSTITUTE SEEING R&D RETURNS

5 April 1993

SWEDEN'S PHARMA MARKET IN 1992

5 April 1993

IRISH HIV BLOOD CLAIMS TO GO AHEAD

29 March 1993

PHARMACEUTICAL DESIGN: EPITOPE SELECTION

15 March 1993

PHASE I/II ANTI-CD45 TRIAL COMPLETED

15 March 1993

NEW DIRECTOR AT BAXTER

8 March 1993

BAXTER, STUART DEAL CALLED OFF

8 March 1993

BLOOD SUBSTITUTE R&D: HOW IMPORTANT IS NO?

22 February 1993

UNITED BIOMEDICAL PRODUCT UPDATE

22 February 1993

MILES LABS AND RHONE-POULENC REACH AGREEMENT

15 February 1993

BAXTER IN RESEARCH AGREEMENT

1 February 1993

RECORD RESULTS FROM US PHARMA MAJORS

1 February 1993

NEW CHEMICAL ENTITIES LAUNCHED IN 1992

1 February 1993

FDA APPROVES 26 NEWDRUGS IN 1992

25 January 1993

BAXTER TO TEST BLOOD SUBSTITUTE

25 January 1993

US COMPANIES IN BIOTECH LINK-UP

18 January 1993

1992 SEES SMALLER COMPANY MERGERS

4 January 1993

RECOMBINATE APPROVAL IN USA

21 December 1992

NEW PLAYERS IN US DRUG MAIL ORDER

14 December 1992

BAXTER TO BUY DISTRIB BUSINESS

7 December 1992

NIH APPROVE GENE THERAPY TRIALS

5 October 1992

Appointments at Baxter International

22 June 1992

Caremark 1992 sales estimates

22 June 1992

ROUSSEL UCLAF CUTS EURO PLANTS

22 June 1992

US COMPANY NEWS IN BRIEF

15 June 1992

us catalog firm plans drug sales

15 June 1992

US DRUG FIRMS' PUERTO RICO TAX CREDITS

25 May 1992

APPOINTMENTS AT BAXTER

11 May 1992

BAXTER PRESIDENT TO FORM NEW VENTURE

27 April 1992

GOOD SALES GROWTH FOR MAJOR US COS IN 1st QTR

27 April 1992

SOMATOGEN'S rhB1.1 BLOOD SUBSTITUTE

23 March 1992

"KEY" US PATENT FOR BIOPURE'S HEMOPURE

10 February 1992

STOCK MARKET COMMENTARY: NEW YORK

3 February 1992

1991 A YEAR OF STRONG GROWTH IN THE USA

27 January 1992

JOHN BAXTER RESIGNS FROM CAL BIO

27 January 1992

BAXTER EXPANDS IN SINGAPORE

20 January 1992

China blames Baxter for heparin deaths